During the past decade, Florida Gynecologic Oncology conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 11 clinical trials were completed, i.e. on average, 220% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Florida Gynecologic Oncology" #1 sponsor was "National Cancer Institute (NCI)" with 8 trials, followed by "Gynecologic Oncology Group" with 4 trials sponsored, "GOG Foundation" with 3 trials sponsored, "NRG Oncology" with 2 trials sponsored and "Precision Therapeutics" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Florida Gynecologic Oncology" #1 collaborator was "National Cancer Institute (NCI)" with 10 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Gynecologic Oncology Group" with 2 trials as a collaborator, "Aventis Pharmaceuticals" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Florida Gynecologic Oncology" are "Fallopian Tube Endometrioid Adenocarcinoma" (5 trials), "Fallopian Tube Mucinous Adenocarcinoma" (5 trials), "Fallopian Tube Transitional Cell Carcinoma" (5 trials), "Ovarian Brenner Tumor" (5 trials) and "Ovarian Cancer" (5 trials). Many other conditions were trialed in "Florida Gynecologic Oncology" in a lesser frequency.

Most popular intervention types in "Florida Gynecologic Oncology" are "Drug" (19 trials), "Other" (14 trials), "Biological" (8 trials), "Procedure" (5 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (11 trials), "Quality-of-Life Assessment" (11 trials), "Carboplatin" (10 trials), "Laboratory Biomarker Analysis" (9 trials) and "Questionnaire Administration" (6 trials). Other intervention names were less common.

The vast majority of trials in "Florida Gynecologic Oncology" are 22 trials for "Female" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "Florida Gynecologic Oncology". undefined are not yet recruiting, 1 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Florida Gynecologic Oncology, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Florida Gynecologic Oncology, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".